ArticleCureus2026
A Study on the Analgesic Effects of Two Different Doses of Morphine Added to Intrathecal Levobupivacaine in Cesarean Section: A Randomized Double-Blind Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIntrathecal morphine is considered the gold standard for post-cesarean analgesia. However, opioid-related adverse effects, especially with larger doses, limit its uniform adoption in clinical practice. We aimed to compare the analgesic efficacy and safety profile of two doses of morphine (50 µg and 100 µg) added to intrathecal hyperbaric levobupivacaine in parturients undergoing elective cesarean section. MATERIALS AND
methodsThis prospective randomized double-blind study included a total of 76 parturients scheduled for elective cesarean section under spinal anesthesia, who were randomized to receive 10 mg of 0.5% hyperbaric levobupivacaine with either 50 µg (Group A) or 100 µg (Group B) of intrathecal morphine. Other outcomes that were assessed include postoperative pain scores, requirement for additional analgesics, and maternal and fetal adverse events.
resultsFollowing the exclusion of two patients from Group A, 74 patients were included in the statistical analysis (Group A, n=36; Group B, n=38). Demographic characteristics and perioperative hemodynamics were comparable between the two groups. The median time (minutes) to the first analgesic request was similar in both groups (Group A: 363 (interquartile range (IQR): 207-442) vs. Group B: 365 (IQR: 200-445), P=0.931). However, a significantly higher proportion of patients in Group A required supplemental nonsteroidal anti-inflammatory drugs (NSAIDs) during the assessment period. The incidence of maternal adverse effects, such as pruritus (33.3% vs. 21.1%, P=0.234) and postoperative nausea and vomiting (PONV) (13.8% vs. 14.3%, P=0.462), was comparable between the two groups, and none of the patients developed respiratory depression or hypoxia. Perioperative hemodynamic parameters and neonatal outcomes assessed by Apgar scores were similar between groups.
conclusionIn this study, both 50 µg and 100 µg doses of intrathecal morphine provided effective and safe postoperative analgesia following elective cesarean section. However, the 100 µg dose demonstrated superior analgesia in terms of a reduced requirement for supplemental NSAIDs, rather than a difference in the time to first analgesic request. As this benefit was achieved without an increase in opioid-related side effects, 100 µg of intrathecal morphine may be the preferred dosage for post-cesarean analgesia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.